Petmed Express Sees Unusually Large Options Volume (PETS)
Petmed Express Inc (NASDAQ:PETS) was the recipient of unusually large options trading activity on Thursday. Traders acquired 963 put options on the company. This represents an increase of approximately 783% compared to the typical daily volume of 109 put options.
Shares of NASDAQ PETS opened at $36.80 on Friday. The firm has a market cap of $749.02 million, a price-to-earnings ratio of 20.08 and a beta of 0.54. Petmed Express has a 52-week low of $31.81 and a 52-week high of $57.80.
Petmed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, July 23rd. The company reported $0.62 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.01). The company had revenue of $87.39 million for the quarter, compared to the consensus estimate of $85.72 million. Petmed Express had a net margin of 14.42% and a return on equity of 35.77%. The firm’s revenue was up 9.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 earnings per share. equities research analysts anticipate that Petmed Express will post 2.28 EPS for the current year.
In other Petmed Express news, Director Robert C. Schweitzer sold 7,500 shares of Petmed Express stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $37.00, for a total transaction of $277,500.00. Following the sale, the director now owns 88,334 shares in the company, valued at $3,268,358. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.70% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of PETS. Redwood Investments LLC bought a new position in shares of Petmed Express during the first quarter valued at $13,425,000. Brown Advisory Inc. bought a new position in shares of Petmed Express during the first quarter valued at $401,000. Xact Kapitalforvaltning AB bought a new position in shares of Petmed Express during the second quarter valued at $242,000. Bank of Montreal Can lifted its holdings in shares of Petmed Express by 46.4% during the second quarter. Bank of Montreal Can now owns 16,689 shares of the company’s stock valued at $735,000 after acquiring an additional 5,292 shares during the period. Finally, Scout Investments Inc. bought a new position in shares of Petmed Express during the second quarter valued at $3,563,000. 95.68% of the stock is owned by institutional investors.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Further Reading: Should you buy a closed-end mutual fund?
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.